News
SRZNW
0.0221
0.00%
0.0000
Weekly Report: what happened at SRZNW last week (0422-0426)?
Weekly Report · 12h ago
Weekly Report: what happened at SRZNW last week (0415-0419)?
Weekly Report · 04/22 10:39
Surrozen Inc reports results for the quarter ended in December - Earnings Summary
Surrozen Inc reports results for the quarter ended in December. Reported revenue was zero; analysts expected zero. The company reported a quarterly loss of $8.91 million. Surrozen Inc shares had fallen by 37.9% this quarter and gained 3.7% so far this year.
Reuters · 04/16 21:03
RA CAPITAL MANAGEMENT, L.P. REPORTS 9.99% PASSIVE STAKE IN SURROZEN AS OF APRIL 4 - SEC FILING
Reuters · 04/15 20:48
Weekly Report: what happened at SRZNW last week (0408-0412)?
Weekly Report · 04/15 10:32
Surrozen, Inc. Annual Report for the Fiscal Year Ended December 31, 2023
Press release · 04/10 23:01
Weekly Report: what happened at SRZNW last week (0401-0405)?
Weekly Report · 04/08 10:36
BUZZ-U.S. STOCKS ON THE MOVE-Eiger BioPharmaceuticals, Reddit, US energy sector
Stronger-than-expected manufacturing data propped up Treasury yields and tempered expectations of a rate cut in June. The Dow Jones Industrial Average was down 0.75% in midday trading on Monday. The top three S&P 500 percentage gainers were Micron Technology, Wynn Resorts.
Reuters · 04/01 17:47
SURROZEN INC -PHASE 1A TRIAL DEMONSTRATED ACCEPTABLE SAFETY AND TOLERABILITY WITH NO REPORTED SERIOUS ADVERSE EVENTS
Reuters · 04/01 12:32
SURROZEN INC -PHASE 1A DATA DEMONSTRATED TARGET ENGAGEMENT, A PHARMACODYNAMIC EFFECT AND EFFECTS ON LIVER FUNCTION
Reuters · 04/01 12:32
SURROZEN INC - INTENDS TO USE NET PROCEEDS FROM PRIVATE PLACEMENT TO FUND SZN-043 CLINICAL DEVELOPMENT PROGRAM
Reuters · 04/01 12:30
SURROZEN ANNOUNCES UP TO $192.5 MILLION PRIVATE PLACEMENT OF SECURITIES PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 04/01 12:30
Weekly Report: what happened at SRZNW last week (0325-0329)?
Weekly Report · 04/01 10:35
Weekly Report: what happened at SRZNW last week (0318-0322)?
Weekly Report · 03/25 10:37
Weekly Report: what happened at SRZNW last week (0311-0315)?
Weekly Report · 03/18 10:35
Weekly Report: what happened at SRZNW last week (0304-0308)?
Weekly Report · 03/11 10:33
Weekly Report: what happened at SRZNW last week (0226-0301)?
Weekly Report · 03/04 10:36
Weekly Report: what happened at SRZNW last week (0219-0223)?
Weekly Report · 02/26 10:44
Weekly Report: what happened at SRZNW last week (0212-0216)?
Weekly Report · 02/19 10:46
More
Webull provides a variety of real-time SRZNW stock news. You can receive the latest news about Surrozen Inc through multiple platforms. This information may help you make smarter investment decisions.
About SRZNW
Surrozen, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a range of organs and tissues. The Company's lead product candidates are multi-specific, antibody-based therapeutics that mimic the roles of naturally occurring Wnt or R-spondin proteins, which are involved in activation and enhancement of the Wnt pathway. Its two technologies, Surrozen Wnt signal Activating Protein (SWAP) and Surrozen Wnt signal Enhancers Engineered for Tissue Specificity (SWEETS), enable it to potently and selectively modulate Wnt signaling through the generation of Wnt and R-spondin mimetics. SWAP molecules are designed to mimic the activity of naturally occurring Wnt proteins. SWEETS molecules are designed to amplify the body’s response to naturally occurring Wnt proteins. Its product candidates include SZN-1326, SZN-043 and SZN-413.